Monster plaques: What they tell us about Alzheimer's disease

1. Sherrington, R. et al. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature 375, 754−760 (1995). | Article | PubMed  | ISI | ChemPort |
2. Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269,973−977(1995). | PubMed  | ChemPort |
3. Kwok, J.B. et al. Two novel (M233T and R278T) pre-senilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 8, 1537−1542 (1997). | PubMed  | ISI | ChemPort |
4. Crook, R. et al. A variant of Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques due to deletion of exon 9 of presenilin 1. Nature Med. 4, 452−455 (1998). | Article | PubMed  | ISI | ChemPort |
5. Suzuki, N. et al. An increased percentage of long amyloid protein secreted by familial amyloid protein precursor (APP717) mutants. Science 264, 1336−1340(1994). | PubMed  | ISI | ChemPort |
6. Scheuner, D. et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin-1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2,864−870 (1996). | PubMed  | ISI | ChemPort |
7. Duff, K. et al. Increased amyloid-42(43) in brains of mice expressing presenilin 1. Nature 383, 710−713 (1996). | Article | PubMed  | ISI | ChemPort |
8. Borchelt, D.R. et al. Familial Alzheimer's disease-linked presenilin-1 variants elevate A1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005−1013 (1996). | Article | PubMed  | ISI | ChemPort |
9. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med. 3, 67−72 (1997). | PubMed  | ISI | ChemPort |
10. Jarrett, J.T. & Lansbury, P.T. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73,1055−1058(1993). | PubMed  | ISI | ChemPort |
11. Yankner, B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921−932 (1996). | Article | PubMed  | ISI | ChemPort |
12. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C. Neurodegeneration induced by -amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13,1676−1687 (1993). | PubMed  | ISI | ChemPort |
13. Mattson, M.P., Tomaselli, K.J. & Rydel, R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FCF. Brain Res. 621,35−49 (1993). | Article | PubMed  | ISI | ChemPort |
14. Lorenzo, A. & Yankner, B.A. Beta-amyloid neurotoxi-city requires fibril formation and is inhibited by Congo Red. Proc. Natl. Acad. Sci. USA 91, 12243−12247(1994). | PubMed  | ChemPort |
15. Nochlin, D., Bird, T.D., Nemens, E.J., Ball, M.J & Sumi, S.M. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N¹⁴¹). Ann. Neurol. 43, 131−135 (1998). | PubMed  | ISI | ChemPort |

	Top

	Top